Human exposure guidelines for halogenated hydrocarbons (halons) and halon replacement chemicals have been established using doeresponse data obtained from canine cardiac sensitization studies. In order to provide a tool for decision makers and regulators tasked with setting guidelines-for egress from exposure to halon replacement chemicals, a quantitative approach, using a PhYsiolosi~Y P -. etic madel, was established that allowed expasures to be d in terms of the chemical concentrations in blood during the exposure. This model, which includes a respiratory tract compartment containing a dead-space region, a pulmonary exchange area, and a breath-by-breath description of respiratory tract uptake, allows successful simulation of exhaled breath concentrations of humans during the first minute of exposure to the anesthetics halothane, isdhuane, and desflurane. In the current study, the human model was modified with canine parameters and validated with data OMained from dog studies with halothane, isoflurane, desfiurane, and CFC-11. With consideration of appropriate values for ventilation and cardiac output, the model successfully simulated data collected under a variety of expoawe scenarios. The raninexnodel can be used for simulating blood concentrations associated with the potential for cardiac sensitization. These target blood concentrations can then be used with the human mode4 for establishing safe human e m sure duration. Development of the canine model stresses the need for appropriate data collection for model validation.
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Replacement of ozone-depleting substances (ODs) has required quantitative toxicological evaluation of halon replacement chemicals. Historically. these volatile halogenenated organic compounds have been regulated on the basis of cardiac sensitization tests conducted in dogs (U.S. EPA, 1994) . The dogs are challenged simultaneously with epinephrine and the test chcmical of interest, while cardiac electrical activity is monitored for cardiac arrhythmia. The test is conducted at increasing concentrations of the test chcmical in order to determine a no-observed-adverse-effect level (NOAEL) and a lowest-observed-adverse-effect level (LOAEL). Vinegar and Jepsan (1996) . Implementation of the procedure required modification of the respiratory tract (RT) compartment description commonly uscd in PBPK models (Vinegar et ai., 1998). Usually, the PBPK RT compartment uses a steady-state approximation that results in an initial, unrealistically high arterial blood concentration. The steady-state approximation is suitable for describing inhalation exposures lasting from minutes to hours but is not able to describe the first second to minute of an exposure. Using the model with the modified RT, Vinegar et af. (2000) described a procedure for setting safe acute exposure limits for halon replacement chemicals. They linked the cardiac sensitization endpoint, after 5 niin of exposure to the LOAEL concentration, to the associated arterial concentration. This arterial concentration measured in dogs was then used as the target concentration for simulated human exposures. For a given exposure concentration, the time until a human reached the target arterial concentration was considered safe from the potential for cardiac sensitization. However, pharmacokinetic studies in dogs are expensive. If a canine PBPK model could be used to predict the &rial concentration, the major experimental cost would be for the determination of partition coefficients.
The purpose of this study was to m d i and validate an existing PBPK model for use with dogs. The model was originally developed to predict blood and exhaled breath chemical concentrations in humans during inhalation exposures of less than 5 minutes duration and includes a breath-by-breath description of inhalation in humans (Vinegar et ul., 2000) . Several data sets were found in the literature, containing pharmacokinetic data in dogs that were exposed by inhalation to the volatile anesthetics halothane (2-bromo-2chloro-1,1, I-trifluoroethane), isoflurane (2-chloro-2-[difluoromethoxy]-1 ,I ,I -trifluoroethane), and desflurane (2-fluoro-2-[difluromethoxy~-1 , 1 ,1-trifluoroethane) and to the chlorofluorocarbon CFC-I 1 (trichlorofluoromethane). An additional data set was found where CFC-11 was administered by intravenous injection. tion of 28 mg of CFC-11 (Fig. 2) . The model tends to overpredict venous concentration from 0.4 to 0.8 h and underpredict from 1.8 to 3.5 h.
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Arterial and alveolar concentrations are well simulated under changing inspired concentrations of isoflurane for dog 1 (Fig. 3) . However, arterial concentration is consistently overpredicted for dog 2, even with good model fit for alveolar concentrations. Simulations are shown for arterial. venous, and alveolar concentrations during and after exposure to halothane and isoflurane (Fig. 4) . Overlapping simulations are shown that differ from 100 min to the end of the exposure.
During this time cod, the upper curve is a result of alveolar ventilation being set equal to cardiac output, while the lower curve results from alveolar ventilation being set equal to 1 0 of cardiac output (see Discussion section for explanation).
Simulation of arterial concentration is shown during half-hourly, 0.5% stepped increases in inhaled concentration up to 2.0% (Fig. 5) . Data shown at the end of each half hour are generally well represented by the model, although somewhat overpredicted at 2.0%. Wilhelnr (personal communication) . Alveolar concentrations for desflurane and isoflurane are shown during and after exposure (Fig. 6 ). Desflurane and isoflurane data are generally well predicted both during and after exposure.
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DISCUSSION
Using ventilation and inspired concentration. actually measured during the course of an inhalation exposure, has been demonstrated to lead to successful simulation of pharmacokinetic data collected during the study. Exhaled breath concentrations of rats exposed to chloropentafluorobenzene were successfully simulated when measured minute ventilation was incorporated into the model (Vinegar et ul., 1990) . Similarly, exbaled concentrations of humans exposed to anesthetics were successfully simulated on a breath-by-breath basis when ventilation and inspired concentration were incorporated into the model (Vinegar et al., 1998) .
The data used to validate the breath-by-breath dog model
were collected under varying protocols, which resulted in variability in ventilation and cardiac output. Hughes et al. (1980) . also after 30 min of 1.5% halothane exposure. Dogs exposed to desflurane while spontaneously breathing showed cardiac outputs of 128, 115, and 96 ml/kg/min and respiratory rates of 37, 47, and 22 at end tidal exposures of 10.3, 12.9, and IS.&%, respectively (Clarke et al., 1996) .
Measurements of respiration rate and tidal volume were made in spontaneously breathing dogs exposed for 40 min, via tracheal intubation, to 1.352 halothane or 1.95% isotlurane (Hellebrekers, 1986) . They had previously been exposed to up to 4.54 of each agent by face mask in order to anesthetize them for the tracheal intuhation. Respiratory rates increased for both agents during the 40-min period, although the rates for halothane were generally nearly twice those for isoflurane.
Larger changes were Seen in tidal volume, which initially dropped for 5 min, leveled off, and then started to increase at 30 min with values approaching control levels at 40 min.
Halothane produced greater decreases in tidal volume than did isoflurane.
In light of the variability of ventilation and cardiac output during the exposures described, it is useful to consider the 
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difference in the behavior of the model, comparing default values for ventilation and cardiac output with values that take into account the changes that might result from the exposure. Of the data sets used, the most complete is that of Frei er al.
(1988) (Fig. 4) . Measurements of inspired, end-expired, arterial, and mixed venous concentrations wete made and reported for 160 min of exposure and 50 min of washout of the anesthetics halothane and isoflurane. Cardiac output was also measllled and reported over the same time period. Ventilation was maintained at 12 breaths per min. but tidal volume was varied to maintain constant arterial PaCO,. Periods of hyperventilation and hypercirculation were induced during the course of the experiment. The data provided in this study were useful for probing the effects of ventilation, perfusion, and ventilation:
perfusion ratio (WR) on the ability of the model to simulate a @veri data set. Sinceicardiac output data were available, the anz plotted with bars representing one standard deviauon above and below the mean actual cardiac output was used in the model and ventilation was calculated based on the VPR. The actual arterial, venous, and alveolar concentrations do not show significant change during the course of the exposure, because the anesthetic was administered with a fcedback-controllcd delivery system. Howcver. initial simulations of arterial, venous, and alveolar concentration all show a sharp rise at around 100 min, which is when hypercirculation was induced with epinephrine. These simulations were performed initially with the assumption that the VPR was 1 throughout the experiment. However, the induced hypen5xculation does not necessarily result in a corresponding change in ventilation. Epinephrine has a profound effect on cardiac output but also results in increased ventilation. The increased ventilation would lead to reduced pCOl and according to the protocol, would have resulted in the tidal volume delivered by the ventilator being reduced to allow a return to normal pCO? levels. Setting the VPR to 0.5 during the period of hypercirculation resulted in the simulations more closely predicting the actual data (see Fig. 4 , lower curves). Ventilation was mea3ured at times of sample taking for analysis, but the data were not reported. Ventilation and cardiac output are major contributors to the model's ability to simulate actual data, but another contributing factor may be the concomitant changes in the distributlon of cardiac output as a result of anesthetic exposure and of other manipulations, such as the intentional induction of hypercirculation reported in this study Ahlgren et al. (1978) presented data demonstrating effects of halothane exposure on the distribution of cardiac output. Significant changes were seen in flows to some organs. Data were presented for 30 and 60 min of exposure to 1.5% halothane. Unfortunately, there are not enough data to incorporate into the model. Although Wilhelm (personal communication) measured inspired and expired (end tidal and mixed) agent concentrations, respiratory rate, and tidal volume on a breath-by-breath basis, the only data provided were the expired concentrations at selected time points and the target inhaled concentration. However, the volume of anesthetic administered was also provided. This wa5 used to set the ventilatory parameters for the model. Fixing the frequency at 12 breaths per minute, a tidal volume of 185 ml provided simulated inspired volumes for hoflurane and desflurane of 9377 and 47,632 ml, respectively. The respective measured, inspired volumes were 9388 and 47,661 ml Using the ventilatory parameters determined in this way resulted in the simulations of alveolar concentration shown in Figure 6 . 
